Design of high-specificity binders for peptide–MHC-I complexes
University of Washington · Memorial Sloan Kettering Cancer Center · +8 more institutions
Abstract
Class I major histocompatibility complex (MHC-I) molecules present peptides derived from intracellular antigens on the cell surface for immune surveillance. Proteins that recognize peptide-MHC-I (pMHCI) complexes with specificity for diseased cells could have considerable therapeutic utility. Specificity requires recognition of outward-facing amino acid residues within the disease-associated peptide as well as avoidance of extensive contacts with ubiquitously expressed MHC. We used RFdiffusion to design pMHCI-binding proteins that make extensive contacts with the peptide and identified specific binders for 11 target pMHCs starting from either experimental or predicted pMHCI structures. Upon incorporation into…
Citation impact
- FWCI
- 25.87
- Percentile
- 100%
- References
- 37
Authors
17Topics & keywords
- Major histocompatibility complex
- Peptide
- Antigen
- MHC class I
- Biology
- MHC restriction
- T-cell receptor
- Cell biology
- Good health and well-being
Funding
- NSNational Science FoundationAwards: 2045054, CA008748, CAREER, P30 CA008748
- UDU.S. Department of DefenseAwards: CA008748, P30 CA008748
- WRWashington Research Foundation
- CHChildren's Hospital of Philadelphia
- PIParker Institute for Cancer ImmunotherapyAward: P30 CA008748
- MFMark Foundation For Cancer Research
- CRCancer Research UKAwards: CGCATF-2023/100008, CGCATF-2023/100006
- NINational Institutes of HealthAwards: P30 CA008748, R35 CA241894, GM142795, R35 GM142795
- NCNational Cancer InstituteAwards: CA008748, P30 CA008748, R35 CA241894